Increased Fas antigen expression in murine retrovirus-induced immunodeficiency syndrome, MAIDS. 1994

K Hiromatsu, and Y Aoki, and M Makino, and Y Matsumoto, and T Mizuochi, and Y Gotoh, and K Nomoto, and J Ogasawara, and S Nagata, and Y Yoshikai
Laboratory of Germfree Life, Research Institute for Disease, Nagoya University School of Medicine, Japan.

The Fas antigen (Fas), which is a cell surface protein belonging to the tumor necrosis factor receptor family, mediates apoptosis. To assess the contribution of Fas to the pathogenesis of retrovirus-induced immunodeficiency, we examined the kinetics of Fas expression on the lymphocytes during the course of murine acquired immunodeficiency syndrome (MAIDS) induced by a defective LP-BM5 murine leukemia virus. The Fas-positive cells were increased in proportion both in alpha beta T cells and B cells with the progression of MAIDS. The appearance of Fas-positive cells in alpha beta T cells preceded those in B cells during the course of MAIDS. Among alpha beta T cells, about half of the Thy1.2+ alpha beta T cells were positive for Fas, while almost all of Thy1.2- CD4+ alpha beta T cells were of the Fas-positive phenotype. The Fas-positive cells in MAIDS mice, especially unique Thy1.2-CD4+ alpha beta T cells, were easily rendered apoptotic by stimulation via Fas, indicating that Fas expressed on the lymphocytes is functional. Furthermore, concomitant infection with Mycobacterium avium in MAIDS mice caused a marked increase in Fas-positive cells accompanied by a severely impaired T cell reactivity to polyclonal stimuli. Taken together, these results suggest that possible participation of the Fas system in the pathogenesis of retrovirus-induced immunodeficiency.

UI MeSH Term Description Entries
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D009162 Mycobacterium avium A bacterium causing tuberculosis in domestic fowl and other birds. In pigs, it may cause localized and sometimes disseminated disease. The organism occurs occasionally in sheep and cattle. It should be distinguished from the M. avium complex, which infects primarily humans.
D004249 DNA Damage Injuries to DNA that introduce deviations from its normal, intact structure and which may, if left unrepaired, result in a MUTATION or a block of DNA REPLICATION. These deviations may be caused by physical or chemical agents and occur by natural or unnatural, introduced circumstances. They include the introduction of illegitimate bases during replication or by deamination or other modification of bases; the loss of a base from the DNA backbone leaving an abasic site; single-strand breaks; double strand breaks; and intrastrand (PYRIMIDINE DIMERS) or interstrand crosslinking. Damage can often be repaired (DNA REPAIR). If the damage is extensive, it can induce APOPTOSIS. DNA Injury,DNA Lesion,DNA Lesions,Genotoxic Stress,Stress, Genotoxic,Injury, DNA,DNA Injuries
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000954 Antigens, Surface Antigens on surfaces of cells, including infectious or foreign cells or viruses. They are usually protein-containing groups on cell membranes or walls and may be isolated. Cell Surface Antigens,Surface Antigens,Surface Markers, Immunological,Cell Surface Antigen,Immunologic Surface Markers,Markers, Immunological Surface,Surface Antigen,Surface Markers, Immunologic,Antigen, Cell Surface,Antigen, Surface,Antigens, Cell Surface,Immunological Surface Markers,Markers, Immunologic Surface,Surface Antigen, Cell,Surface Antigens, Cell
D001402 B-Lymphocytes Lymphoid cells concerned with humoral immunity. They are short-lived cells resembling bursa-derived lymphocytes of birds in their production of immunoglobulin upon appropriate stimulation. B-Cells, Lymphocyte,B-Lymphocyte,Bursa-Dependent Lymphocytes,B Cells, Lymphocyte,B Lymphocyte,B Lymphocytes,B-Cell, Lymphocyte,Bursa Dependent Lymphocytes,Bursa-Dependent Lymphocyte,Lymphocyte B-Cell,Lymphocyte B-Cells,Lymphocyte, Bursa-Dependent,Lymphocytes, Bursa-Dependent
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D014376 Tuberculosis Any of the infectious diseases of man and other animals caused by species of MYCOBACTERIUM TUBERCULOSIS. Koch's Disease,Kochs Disease,Mycobacterium tuberculosis Infection,Infection, Mycobacterium tuberculosis,Infections, Mycobacterium tuberculosis,Koch Disease,Mycobacterium tuberculosis Infections,Tuberculoses

Related Publications

K Hiromatsu, and Y Aoki, and M Makino, and Y Matsumoto, and T Mizuochi, and Y Gotoh, and K Nomoto, and J Ogasawara, and S Nagata, and Y Yoshikai
July 1995, Pathology, research and practice,
K Hiromatsu, and Y Aoki, and M Makino, and Y Matsumoto, and T Mizuochi, and Y Gotoh, and K Nomoto, and J Ogasawara, and S Nagata, and Y Yoshikai
November 1988, Journal of immunology (Baltimore, Md. : 1950),
K Hiromatsu, and Y Aoki, and M Makino, and Y Matsumoto, and T Mizuochi, and Y Gotoh, and K Nomoto, and J Ogasawara, and S Nagata, and Y Yoshikai
August 1988, The Journal of experimental medicine,
K Hiromatsu, and Y Aoki, and M Makino, and Y Matsumoto, and T Mizuochi, and Y Gotoh, and K Nomoto, and J Ogasawara, and S Nagata, and Y Yoshikai
February 1994, Scandinavian journal of immunology,
K Hiromatsu, and Y Aoki, and M Makino, and Y Matsumoto, and T Mizuochi, and Y Gotoh, and K Nomoto, and J Ogasawara, and S Nagata, and Y Yoshikai
March 1993, Clinical and experimental immunology,
K Hiromatsu, and Y Aoki, and M Makino, and Y Matsumoto, and T Mizuochi, and Y Gotoh, and K Nomoto, and J Ogasawara, and S Nagata, and Y Yoshikai
June 1987, The Journal of experimental medicine,
K Hiromatsu, and Y Aoki, and M Makino, and Y Matsumoto, and T Mizuochi, and Y Gotoh, and K Nomoto, and J Ogasawara, and S Nagata, and Y Yoshikai
January 1992, Archives of dermatological research,
K Hiromatsu, and Y Aoki, and M Makino, and Y Matsumoto, and T Mizuochi, and Y Gotoh, and K Nomoto, and J Ogasawara, and S Nagata, and Y Yoshikai
October 1993, Science (New York, N.Y.),
K Hiromatsu, and Y Aoki, and M Makino, and Y Matsumoto, and T Mizuochi, and Y Gotoh, and K Nomoto, and J Ogasawara, and S Nagata, and Y Yoshikai
July 1994, Science (New York, N.Y.),
K Hiromatsu, and Y Aoki, and M Makino, and Y Matsumoto, and T Mizuochi, and Y Gotoh, and K Nomoto, and J Ogasawara, and S Nagata, and Y Yoshikai
July 1994, Science (New York, N.Y.),
Copied contents to your clipboard!